Article
Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients.
Biochimica et biophysica acta - 1 Jan 2000
van Kuilenburg André B P, Dobritzsch Doreen, Meijer Judith, Meinsma Rutger, Benoist Jean-François, Assmann Birgit, Schubert Susanne, Hoffmann Georg F, Duran Marinus, de Vries Maaike C, Kurlemann Gerd, Eyskens François J M, Greed Lawrence, Sass Jörn Oliver, Schwab K Otfried, Sewell Adrian C, Walter John, Hahn Andreas, Zoetekouw Lida, Ribes Antonia, Lind Suzanne, Hennekam Raoul C M
Abstract excerpt
Dihydropyrimidinase (DHP) is the second enzyme of the pyrimidine degradation pathway and catalyses the ring opening of 5,6-dihydrouracil and 5,6-dihydrothymine. To date, only 11 individuals have been reported suffering from a complete DHP deficiency. Here, we report on the clinical, biochemical and molecular findings of 17 newly identified DHP deficient patients as well as the analysis of the mutations in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
